DCX and Alzheimer disease: When administered to AD mice, there was a marked increase in the levels of Sox2+/GFAP+ NSCs, Ki67+ proliferating cells, and DCX+ neuroblasts in the hippocampal dentate gyrus, SVZ, and the cortex [96].